Analyses of Anemia in Very Low Birth Weight (VLBW) Infants.

Sponsor
Shenzhen Bao'an Maternal and Child Health Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05949788
Collaborator
Longhua Hospital Of Baoan District, Shenzhen (Other)
110
1
12
9.1

Study Details

Study Description

Brief Summary

To study and analyze the association of the severity of anemia with neonatal morbidity and the risk factors of anemia in ealry life (less than 3 days of life) among the very low birth weight (VLBW) infants.

Condition or Disease Intervention/Treatment Phase
  • Other: No intervention

Detailed Description

The rescue treatment of very low birth weight (VLBW) infants is the main task of our neonatal intensive care unit (NICU) is this era. Anemia of prematurity (AOP) is one of the most common complication of these infants, which can affect their growth, intelligence, behavior, immunity and hemodynamics, and even endanger their lives in severe situation. It is of great significance to investigate the association of the severity of anemia with neonatal morbidity and the risk factors of anemia in ealry life for improving the prognosis of these infants.

Patient Registry procedures: First, the list of VLBW infants was obtained through medical record search, and sent to the principal investigator (PI) at each center when an infant was eligible for enrollment. Second, patients are included in this study according to the exclusion criteria by PI. Finally, the PI at each center will be responsible for the accuracy,completeness or representativeness of medical records, registry forms,data collection.

Statistical analysis:The two groups were compared by a Χ2-test for categorical variables, Mann-Whitney U Test were used when reporting medians.A P value of <0.05 was considered statistically significant.

Study Design

Study Type:
Observational
Anticipated Enrollment :
110 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Analyses of Anemia Risk Factors and Prognosis in VLBW Infants.
Actual Study Start Date :
Mar 1, 2023
Anticipated Primary Completion Date :
Jul 31, 2023
Anticipated Study Completion Date :
Mar 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Anemia group

The very low birth weight (VLBW) infants meet the diagnostic criteria of neonatal anemia during hospitalization between January 2020 and January 2023.

Other: No intervention
Retrospect study, no direct intervention

Control group

The very low birth weight (VLBW) infants are included without anemia during hospitalization between January 2020 and January 2023.

Other: No intervention
Retrospect study, no direct intervention

Outcome Measures

Primary Outcome Measures

  1. Anemia of prematurity (AOP) development in very low birth weight (VLBW) infants [Through study completion, an average of three months]

    The incidence of AOP in the first 72 hours of life in VLBW infants

Secondary Outcome Measures

  1. Risk factor of AOP among VLBW infants [Through study completion, an average of three months]

    The maternal hemoglobin (Hb) levels before birth among VLBW infants with AOP and without.

  2. Mortality or Bronchopulmonary Dysplasia (BPD) among VLBW infants with AOP [Through study completion, an average of three months]

    The incidence of death or BPD among VLBW infants with AOP and without.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 4 Months
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Preterm infants less than 32 weeks of gestational age and birth weight below 1500 g and who survive to NICU are eligible for the trial.

  • Anemia was defined as a central venous hemoglobin harvested in the first 3 days of life less than two standard deviations below the mean for postnatal age.

Exclusion Criteria:
  • Asphyxia (arterial pH <7.0, fifth minute Apgar score <3),

  • Twin-to twin-transfusion syndrome,

  • Discordant twins (difference in birth weight >20%),

  • Major congenital anomalies or chromosomal anomalies,

  • Disagree of parents.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Shenzhen Bao'an Maternal and Child Health Hospital Shenzhen Guangdong China 518102

Sponsors and Collaborators

  • Shenzhen Bao'an Maternal and Child Health Hospital
  • Longhua Hospital Of Baoan District, Shenzhen

Investigators

  • Study Director: Jun Luo, M.D., Shenzhen Bao'an Maternal and Child Health Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Jun Luo, Principal Investigator, Shenzhen Bao'an Maternal and Child Health Hospital
ClinicalTrials.gov Identifier:
NCT05949788
Other Study ID Numbers:
  • ShenzhenBMCHH
First Posted:
Jul 18, 2023
Last Update Posted:
Jul 18, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Jun Luo, Principal Investigator, Shenzhen Bao'an Maternal and Child Health Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 18, 2023